Literature DB >> 8419148

Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats.

S Hauguel-de Mouzon1, P Peraldi, F Alengrin, E Van Obberghen.   

Abstract

Membrane-associated tyrosine phosphatase activities were studied in two distinct states of insulin resistance: diabetes and pregnancy. Using a novel immunoenzymatic assay with intact insulin-like growth factor-I (IGF-I) and insulin receptors as substrates, we show that phosphotyrosine-protein phosphatases (PTP-ases) from normal rat tissues induce a decrease in tyrosine phosphorylation of both receptors. Membrane fractions from kidney, brain, and liver contain the highest PTP-ase activity toward the insulin receptor. After 20-day streptozotocin-induced diabetes, PTP-ase activities are increased by 70% in the placenta, reduced by 40-50% in liver and skeletal muscle, and remained unchanged in the nonclassical insulin target tissues, kidney and brain. In general, the dephosphorylation of IGF-I receptor follows a pattern similar to that of insulin receptor except in red skeletal muscle in which it is not modified. Pregnancy also induces alterations of liver PTP-ases similar to those elicited by diabetes with a 50% reduction of insulin and IGF-I receptor dephosphorylation. This effect of pregnancy is further potentiated by diabetes. The alterations in the activity of hepatic PTP-ases from diabetic and pregnant rats are associated with a decreased autophosphorylation of the insulin receptor, suggesting that the diminution of phosphatase activity might be associated to the state of receptor phosphorylation and activation. Our data demonstrate that alterations of PTP-ases in insulin target tissues are found in two insulin-resistant states, one characterized by hyperinsulinemia, pregnancy and one by insulinopenia, streptozotocin-diabetes. These observations suggest a possible relationship between the defective activity of receptor tyrosine kinases and membrane-associated phosphatases from insulin responsive tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419148     DOI: 10.1210/endo.132.1.8419148

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Regulation of insulin-stimulated tyrosine phosphorylation of Shc and Shc/Grb2 association in liver, muscle, and adipose tissue of epinephrine- and streptozotocin-treated rats.

Authors:  V Páez-Espinosa; E M Rocha; L A Velloso; M J Saad
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

Review 2.  Transgenic mouse models resistant to diet-induced metabolic disease: is energy balance the key?

Authors:  Laura A A Gilliam; P Darrell Neufer
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

3.  Phosphotyrosine protein phosphatases and diabetic pregnancy: an association between low molecular weight acid phosphatase and degree of glycemic control.

Authors:  F Gloria-Bottini; G Gerlini; N Lucarini; P Borgiani; A Amante; M La Torre; E Antonacci; E Bottini
Journal:  Experientia       Date:  1996-04-15

4.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

Authors:  F Ahmad; J L Azevedo; R Cortright; G L Dohm; B J Goldstein
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

5.  Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects.

Authors:  D Worm; J Vinten; P Staehr; J E Henriksen; A Handberg; H Beck-Nielsen
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

6.  Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice.

Authors:  L D Klaman; O Boss; O D Peroni; J K Kim; J L Martino; J M Zabolotny; N Moghal; M Lubkin; Y B Kim; A H Sharpe; A Stricker-Krongrad; G I Shulman; B G Neel; B B Kahn
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  Insulin receptor dephosphorylation by phosphotyrosine phosphatases obtained from insulin-resistant obese mice.

Authors:  C Olichon-Berthe; S Hauguel-De Mouzon; P Péraldi; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

8.  Glucose-induced stimulation of human insulin-receptor mRNA and tyrosine kinase activity in cultured cells.

Authors:  S Hauguel-de-Mouzon; C Mrejen; F Alengrin; E Van Obberghen
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

9.  Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence.

Authors:  D Worm; A Handberg; E Hoppe; J Vinten; H Beck-Nielsen
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

10.  Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.

Authors:  J Kusari; K A Kenner; K I Suh; D E Hill; R R Henry
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.